You have 9 free searches left this month | for more free features.

Pharmacokinetics SN-38

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer, Breast Cancer, Pancreas Cancer Trial in Seongnam-si, Seoul (SNB-101)

Unknown status
  • Colorectal Cancer
  • +6 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Feb 15, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Biopsy
  • Pegylated SN-38 Conjugate PLX038
  • Rochester, Minnesota
    Mayo Clinic
Jul 19, 2022

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Lymphadenectomy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Cervical Cancer Trial (Sacituzumab Govitecan)

Not yet recruiting
  • Cervical Cancer
  • Sacituzumab Govitecan
  • (no location specified)
Apr 18, 2023

Metastatic Colorectal Cancer Trial (IMMU 130)

Withdrawn
  • Metastatic Colorectal Cancer
  • IMMU 130
  • (no location specified)
Aug 12, 2021

Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma Trial in Barcelona, Madrid, Valencia (CEB-01 membrane loaded

Recruiting
  • Locally Advanced Soft Tissue Sarcoma
  • Recurrent Soft Tissue Sarcoma
  • CEB-01 membrane loaded with SN-38
  • Barcelona, Cataluña, Spain
  • +4 more
Jul 26, 2022

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)

Withdrawn
  • Relapsed Solid Neoplasm
  • +2 more
  • STI-3258
  • (no location specified)
Jan 24, 2023

Metastatic Colorectal Cancer Trial in New York (IMMU-130)

Completed
  • Metastatic Colorectal Cancer
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 12, 2021

Advanced or Metastatic Solid Tumor, Liver Failure Trial in United States (Sacituzumab Govitecan-hziy)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Liver Failure
  • Sacituzumab Govitecan-hziy
  • Long Beach, California
  • +5 more
Jan 6, 2023

Solid Tumors Trial in United States (EZN-2208)

Terminated
  • Solid Tumors
  • Aurora, Colorado
  • +3 more
Jan 29, 2022

Dental Caries in Children Trial in Seattle (38% silver diamine fluoride)

Not yet recruiting
  • Dental Caries in Children
  • 38% silver diamine fluoride
  • Seattle, Washington
    Center for Pediatric Dentistry
Jan 2, 2023

Endometrial Carcinoma Trial in New Haven (Sacituzumab Govitecan)

Recruiting
  • Endometrial Carcinoma
  • Sacituzumab Govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Apr 4, 2022

Hematological Malignancy, Lymphoma Trial in Canton (SG2501)

Recruiting
  • Hematological Malignancy
  • Lymphoma
  • Canton, Ohio
    Gabrail Cancer Center Research, LLC
Aug 3, 2022

Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in United States (IMMU-130)

Withdrawn
  • Metastatic Colorectal Cancer
  • +2 more
  • Santa Monica, California
  • +6 more
Aug 12, 2021

Metastatic Breast Cancer Trial in United States (EZN-2208)

Terminated
  • Metastatic Breast Cancer
  • Sedona, Arizona
  • +35 more
Jan 29, 2022

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Advanced Solid Tumor Trial in Taichung, Taipei (TRX-920 Oral Gel (10 mg and 30 mg))

Recruiting
  • Advanced Solid Tumor
  • TRX-920 Oral Gel (10 mg and 30 mg)
  • Taichung, Taiwan
  • +1 more
Nov 20, 2023

ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

Active, not recruiting
  • ALS
  • Amyotrophic Lateral Sclerosis
  • Irvine, California
  • +13 more
Jan 20, 2023

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Dental Caries Trial in Seattle (38% silver diamine fluoride)

Completed
  • Dental Caries
  • 38% silver diamine fluoride
  • Seattle, Washington
    University of Washington Institute of Translational Health Scien
Jan 11, 2021

Advanced Solid Tumor Trial in Kaohsiung, Tainan (T-1201 Injection 100 mg Kit)

Recruiting
  • Advanced Solid Tumor
  • T-1201 Injection 100 mg Kit
  • Kaohsiung, Taiwan
  • +1 more
Sep 22, 2021

Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Peritoneal Metastases
  • Eindhoven, Netherlands
  • +1 more
Aug 15, 2023